Signos neuromusculares anormales tras la anestesia con romifidina-propofol-halotano en dos algas

Dos galgas (ASA I, con edades de 1.5 y 8 años) incluídas en un estudio anestésico experimental, mostraron signos de una reacción neuromuscular epileptiforme con mioclonías, movimientos natatorios de las extremidades anteriores y opistótonos, durante el inicio de la recuperación anestésica en varios procedimientos anestésicos. Ninguna tenía antecedentes de epilepsia. Las dos fueron anestesiadas con los siguientes protocolos anestésicos: 1. Romifidina (ROM) Ilvl-Atropina (ATR)- Propofol (PRO)-Halotano (HAL), 2. ROM IV-ATRPRO-HAL. 3. Xilacina (XIL)-ATR-PRO-HAL, 4. Medetomidina (MED)-ATR-PRO-HAL y 5. ROMATR-Tiopental sódico (TIO)-HAL. Las perras no fueron sometidas a ninguna intervención quirúrgica. La anestesia se mantuvo durante 60 minutos en todos los casos. Las variables anestésicas y los parámetros sanguíneos estudiados se mantuvieron dentro de los rangos normales. La galga mayor mostró el cuadro descrito en los protocolos 1, 2 y 3 (más marcado en el 2), mientras que la más joven sólo los presentó en el 2, y con una menor intensidad en los signos clínicos. En todos los casos, éstos aparecieron de 2 a 5 minutos después de terminar la administración de halotano, y tras 15 minutos, y adoptar las pacientes el decúbito esternal, los signos cesaron. No fue necesario administrar ningún fármaco para aliviar el cuadro convulsivo. A partir de entonces, la recuperación fue normal y las pacientes no mostraron posteriormente síntomas nerviosos.Two female Greyhounds (ASA I, aged 1.5 and 8 years) showed signs of a neuromuscular epileptiforrn activity, with paddling, opisthotonus and shivering, during the anaesthetic recovery in some anaesthetic protocols. No epilepsy history was registered befare in any patient. The dogs were anaesthetized with the following procedures: 1. Romifidine (ROM) IMAtropine (ATR)-Propofol (PRO)-Halothane (HAL), 2. ROM IV-ATR-PRO-HAL. 3. Xylazine (XIL)-ATR-PROHAL, 4. Medetomidine (MED)-ATR-PRO-HAL y 5. ROM-ATR-Thiopentone (TIO)-HAL. The older Greyhound showed an epileptiforrn activity in the protocols 1, 2 and 3 (more intense in 2), however the younger one only exhibited these signs in the protocol 2. The older one suffered excitatory phenomena deeper than the other one. In all cases, signs began 2-5 minutes after the end of the halothane administration, and after 15 minutes, when the patients adopted the sternal recumbency the signs disappeared. Anaesthetic variables and haematological values were within normal limits. No drug was administered for treating the excitatory phenomena. The recovery was normal and the dogs did not exhibite nervous signs later

Complicaciones en la anestesia general del perro : revisión de 265 casos

Un total de 265 perros fueron anestesiados por diferentes motivos diagnósticos y terapéuticos en los Servicios Clínicos de la Facultad de Veterinaria de Córdoba,siguiendo diversos protocolos anestésicos

Reversión de sedantes agonistas alfa-2-adrenérgicos en el perro

En el presente Artículo de Revisión se aporta una información amplia sobre los productos de LISO más frecuente en la reversión de los efectos sedantes de los agonistas alfa-2-adrenérgicos empleados en el perro: xilacina, medetomidina y romifidina. Se refieren los detalles farmacológicos, dosificación, efectos y aplicaciones de los siguientes productos: yohimbina, 4-aminopiridina, doxapram y atipamezol

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries